Jill Chrencik, Ph.D. - Publications

Affiliations: 
2004 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Structural Studies of Dynamic Cellular Processes

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Chrencik JE, Roth CB, Terakado M, Kurata H, Omi R, Kihara Y, Warshaviak D, Nakade S, Asmar-Rovira G, Mileni M, Mizuno H, Griffith MT, Rodgers C, Han GW, Velasquez J, et al. Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1. Cell. 161: 1633-43. PMID 26091040 DOI: 10.1016/J.Cell.2015.06.002  0.56
2012 Hall T, Shieh HS, Day JE, Caspers N, Chrencik JE, Williams JM, Pegg LE, Pauley AM, Moon AF, Krahn JM, Fischer DH, Kiefer JR, Tomasselli AG, Zack MD. Structure of human ADAM-8 catalytic domain complexed with batimastat. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 68: 616-21. PMID 22684055 DOI: 10.1107/S1744309112015618  0.37
2010 Chrencik JE, Patny A, Leung IK, Korniski B, Emmons TL, Hall T, Weinberg RA, Gormley JA, Williams JM, Day JE, Hirsch JL, Kiefer JR, Leone JW, Fischer HD, Sommers CD, et al. Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6. Journal of Molecular Biology. 400: 413-33. PMID 20478313 DOI: 10.1016/j.jmb.2010.05.020  0.381
2007 Chrencik JE, Brooun A, Recht MI, Nicola G, Davis LK, Abagyan R, Widmer H, Pasquale EB, Kuhn P. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition. The Journal of Biological Chemistry. 282: 36505-13. PMID 17897949 DOI: 10.1074/Jbc.M706340200  0.471
2007 Brooun A, Foster SA, Chrencik JE, Chien EYT, Kolatkar AR, Streiff M, Ramage P, Widmer H, Weckbecker G, Kuhn P. Remedial strategies in structural proteomics: Expression, purification, and crystallization of the Vav1/Rac1 complex Protein Expression and Purification. 53: 51-62. PMID 17275330 DOI: 10.1016/j.pep.2006.10.027  0.408
2006 Chrencik JE, Brooun A, Kraus ML, Recht MI, Kolatkar AR, Gye WH, Seifert JM, Widmer H, Auer M, Kuhn P. Structural and biophysical characterization of the EphB4·EphrinB2 protein-protein interaction and receptor specificity Journal of Biological Chemistry. 281: 28185-28192. PMID 16867992 DOI: 10.1074/jbc.M605766200  0.493
2006 Chrencik JE, Brooun A, Recht MI, Kraus ML, Koolpe M, Kolatkar AR, Bruce RH, Martiny-Baron G, Widmer H, Pasquale EB, Kuhn P. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity. Structure (London, England : 1993). 14: 321-30. PMID 16472751 DOI: 10.1016/j.str.2005.11.011  0.442
2004 Chrencik JE, Staker BL, Burgin AB, Pourquier P, Pommier Y, Stewart L, Redinbo MR. Mechanisms of camptothecin resistance by human topoisomerase I mutations. Journal of Molecular Biology. 339: 773-84. PMID 15165849 DOI: 10.1016/J.Jmb.2004.03.077  0.533
2003 Chrencik JE, Burgin AB, Pommier Y, Stewart L, Redinbo MR. Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex. The Journal of Biological Chemistry. 278: 12461-6. PMID 12533542 DOI: 10.1074/Jbc.M212930200  0.51
Show low-probability matches.